|
DE69429723T2
(de)
|
1993-06-04 |
2002-09-26 |
Whitehead Institute For Biomedical Research, Cambridge |
Stressproteine und ihre verwendung
|
|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
IL123219A0
(en)
|
1995-08-18 |
1998-09-24 |
Sloan Kettering Inst Cancer |
Method for treatment of cancer and infectious diseases and compositions useful in same
|
|
US6773707B1
(en)
|
1995-08-18 |
2004-08-10 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5985270A
(en)
*
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US6130087A
(en)
*
|
1996-10-07 |
2000-10-10 |
Fordham University |
Methods for generating cytotoxic T cells in vitro
|
|
DK0941315T3
(da)
*
|
1996-11-26 |
2006-05-15 |
Stressgen Biotechnologies Corp |
Fusionsproteiner indeholdende stressproteiner til induktion af immunreaktioner
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
WO1998035705A1
(en)
*
|
1997-02-18 |
1998-08-20 |
Whitehead Institute For Biomedical Research |
Use of heat shock proteins to deliver moieties into cells
|
|
BE1011033A6
(fr)
*
|
1997-03-05 |
1999-04-06 |
Univ Bruxelles |
Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
|
|
US6709672B2
(en)
|
1997-03-05 |
2004-03-23 |
Biotech Tools S.A. |
Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction
|
|
EP1336621B1
(en)
*
|
1997-08-05 |
2006-05-24 |
Stressgen Biotechnologies Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
AU779770B2
(en)
*
|
1997-08-05 |
2005-02-10 |
Nventa Biopharmaceuticals Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
PT1336621E
(pt)
*
|
1997-08-05 |
2006-08-31 |
Stressgen Biotechnologies Corp |
Respostas imunitarias contra antigenios dos vph, suscitadas por composicoes que incorporam um antigenio de vph e uma proteina do stress ou um vector de expressao com aptidao para a expressao destas proteinas
|
|
AU2005201826B2
(en)
*
|
1997-08-05 |
2008-01-17 |
Nventa Biopharmaceuticals Corporation |
Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
|
|
IL135860A0
(en)
*
|
1997-10-31 |
2001-05-20 |
Sloan Kettering Inst Cancer |
Conjugate heat shock protein-binding peptides
|
|
WO1999023252A1
(en)
*
|
1997-11-05 |
1999-05-14 |
Isis Innovation Limited |
Cancer gene
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
DE69942810D1
(de)
|
1998-02-20 |
2010-11-11 |
Univ Miami |
Modifizierter Hitzeschockprotein-Antigenpeptid-Komplex
|
|
AU5204199A
(en)
*
|
1998-06-12 |
1999-12-30 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Compositions and methods for modulating proteolytic degradation of intracellulartargets
|
|
US6160088A
(en)
*
|
1998-07-29 |
2000-12-12 |
Sloan-Kettering Institute For Cancer |
KDEL receptor inhibitors
|
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
|
US6497880B1
(en)
|
1998-12-08 |
2002-12-24 |
Stressgen Biotechnologies Corporation |
Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
|
|
EP1196772A2
(en)
|
1999-07-08 |
2002-04-17 |
Stressgen Biotechnologies Corporation |
Induction of a th1-like response in vitro
|
|
AUPQ233799A0
(en)
|
1999-08-19 |
1999-09-09 |
Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales |
Recombinant sub-unit vaccine
|
|
GB9919733D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Colaco Camilo |
Vaccines against intracellular pathogens
|
|
US6984384B1
(en)
|
1999-09-30 |
2006-01-10 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US7378096B2
(en)
|
1999-09-30 |
2008-05-27 |
Health Research, Inc. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US8128922B2
(en)
|
1999-10-20 |
2012-03-06 |
Johns Hopkins University |
Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
DE60042704D1
(de)
|
2000-01-14 |
2009-09-17 |
Whitehead Biomedical Inst |
Induktion zytotoxischer lymphozyten durch hitzeschockprotein-fusionsproteine hängt von der atp-bindungsdomäne in hsp ab und is cd4+ unabhängig
|
|
WO2001078767A2
(en)
*
|
2000-04-14 |
2001-10-25 |
Cistem Biotechnologies Gmbh |
Pharmaceutical preparations comprising modified peptides
|
|
AU2001257087A1
(en)
*
|
2000-04-17 |
2001-10-30 |
Mojave Therapeutics Inc. |
Heat shock protein-based antiviral vaccines
|
|
AU6669401A
(en)
|
2000-06-02 |
2001-12-11 |
Univ Connecticut Health Ct |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
KR100919266B1
(ko)
|
2000-06-26 |
2009-09-30 |
엔벤타 바이오파마슈티컬스 코포레이션 |
인간 파필로마 바이러스 치료법
|
|
US7342002B2
(en)
|
2000-08-03 |
2008-03-11 |
The Johns Hopkins University |
Molecular vaccine linking an endoplasmic chaperone polypeptide to an antigen
|
|
NZ521694A
(en)
|
2002-09-30 |
2005-05-27 |
Co2 Pac Ltd |
Container structure for removal of vacuum pressure
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
PL373675A1
(en)
|
2001-02-05 |
2005-09-05 |
Stressgen Biotechnologies Corporation |
Hepatitis b virus treatment
|
|
GB0106161D0
(en)
*
|
2001-03-13 |
2001-05-02 |
King S College London |
Immunomodulators
|
|
US20040043419A1
(en)
*
|
2001-04-17 |
2004-03-04 |
Rothman James E. |
Javelinization of protein antigens to heat shock proteins
|
|
JP4384489B2
(ja)
|
2001-08-20 |
2009-12-16 |
ユニバーシティー オブ コネティカット ヘルス センター |
癌及び感染性疾患の治療に有用な熱ショックタンパク質又はα−２−マクログロブリンを含む組成物の調製方法
|
|
CN1304559C
(zh)
*
|
2001-10-09 |
2007-03-14 |
杭州康科生物技术有限公司 |
表达热休克蛋白的溶瘤微生物及其应用
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
AU2003231098A1
(en)
|
2002-04-25 |
2003-11-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
WO2004061458A2
(en)
*
|
2003-01-03 |
2004-07-22 |
Aurelium Biopharma Inc. |
Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease
|
|
US7420037B2
(en)
*
|
2003-02-13 |
2008-09-02 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
GB0303507D0
(en)
*
|
2003-02-14 |
2003-03-19 |
Novartis Ag |
Organic compounds
|
|
JP2007525448A
(ja)
*
|
2003-04-11 |
2007-09-06 |
アンティジェニクス インコーポレーテッド |
改良された熱ショックタンパク質に基づくワクチンおよび免疫治療
|
|
US7309491B2
(en)
|
2003-04-11 |
2007-12-18 |
Antigenics Inc. |
Heat shock protein-based vaccines and immunotherapies
|
|
ES2312997T3
(es)
*
|
2003-04-28 |
2009-03-01 |
Sekisui Chemical Co., Ltd. |
Complejo de chaperonina-proteina diana,procedimiento de produccion del mismo,procedimiento de estabilizacion de roteina diana, procedimientode analisis de estructura de proteina diana, preparacion de liberacionprolongada y procedimeinto de anticuerpo contra la proteina diana.
|
|
WO2004098526A2
(en)
|
2003-05-05 |
2004-11-18 |
Johns Hopkins University |
Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
|
|
EP2316844A3
(en)
*
|
2003-05-21 |
2011-07-20 |
Biotech Tools S.A. |
Peptide complex
|
|
ES2396231T3
(es)
|
2003-05-21 |
2013-02-20 |
Biotech Tools S.A. |
Complejo peptídico
|
|
EP1479689A1
(en)
*
|
2003-05-21 |
2004-11-24 |
Biotech Tools S.A. |
Peptide complex
|
|
AU2004274430A1
(en)
|
2003-09-12 |
2005-03-31 |
Antigenics, Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
EP2145896A3
(en)
*
|
2003-11-12 |
2010-03-31 |
Alfa Biogene International B.V. |
Recovery of a heat shock protein
|
|
WO2005065418A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy
|
|
US7449196B2
(en)
*
|
2004-07-09 |
2008-11-11 |
Robert Sabin |
Anti tumor compositions and methods of use
|
|
US20060120995A1
(en)
*
|
2004-12-02 |
2006-06-08 |
Shah Maulik R |
Neoadjuvant genetic compositions and methods
|
|
CA2594040A1
(en)
|
2005-01-06 |
2006-07-13 |
The Johns Hopkins University |
Rna interference that blocks expression of pro-apoptotic proteins potentiates immunity induced by dna and transfected dendritic cell vaccines
|
|
US20070098735A1
(en)
*
|
2005-10-29 |
2007-05-03 |
Chandawarkar Rajiv Y |
Methods for the Elimination of Pathogens and Other Particulate Agents
|
|
WO2007116409A2
(en)
|
2006-04-11 |
2007-10-18 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Improved vaccines comprising multimeric hsp60 peptide carriers
|
|
US20080081051A1
(en)
*
|
2006-09-28 |
2008-04-03 |
Robert Sabin |
Method of manufacturing anti-tumor and anti-viral compositions
|
|
US9085638B2
(en)
|
2007-03-07 |
2015-07-21 |
The Johns Hopkins University |
DNA vaccine enhancement with MHC class II activators
|
|
US20080311145A1
(en)
*
|
2007-04-04 |
2008-12-18 |
Specigen, Inc. |
Protein cage immunotherapeutics
|
|
US8475785B2
(en)
|
2008-03-03 |
2013-07-02 |
The University Of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
US8968720B2
(en)
|
2008-03-20 |
2015-03-03 |
University Of Miami |
Heat shock protein GP96 vaccination and methods of using same
|
|
ES2922534T3
(es)
|
2008-04-18 |
2022-09-16 |
Massachusetts Gen Hospital |
Inmunoterapias que emplean vacunas autoensamblantes
|
|
CN102223894A
(zh)
*
|
2008-11-21 |
2011-10-19 |
迈阿密大学 |
用于产生粘膜和系统免疫的hiv/siv疫苗
|
|
EP2270124A1
(en)
*
|
2009-06-30 |
2011-01-05 |
The Procter & Gamble Company |
Bleaching compositions comprising a perfume delivery system
|
|
US9822154B2
(en)
|
2012-12-14 |
2017-11-21 |
Virginia Commonwealth University |
Immune modulator for immunotherapy and vaccine formulation
|
|
FR3011850B1
(fr)
*
|
2013-10-15 |
2018-04-06 |
Cfl Biotech |
Vaccin therapeutique contre le cancer a base de proteines de stress rendues immunogenes
|
|
SG11201705844SA
(en)
|
2015-02-06 |
2017-08-30 |
Heat Biologics Inc |
Vector co-expressing vaccine and costimulatory molecules
|
|
IL293135A
(en)
|
2015-05-13 |
2022-07-01 |
Agenus Inc |
Composition comprising at least two different complexes of a purified stress protein bound to an antigenic peptide
|
|
WO2017156461A2
(en)
|
2016-03-10 |
2017-09-14 |
Aperisys, Inc. |
Antigen-binding fusion proteins with modified hsp70 domains
|
|
US11666649B2
(en)
|
2016-10-11 |
2023-06-06 |
University Of Miami |
Vectors and vaccine cells for immunity against Zika virus
|
|
CA3058938A1
(en)
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
JP2021522239A
(ja)
|
2018-04-26 |
2021-08-30 |
アジェナス インコーポレイテッド |
熱ショックタンパク質結合ペプチド組成物およびその使用方法
|
|
WO2020231788A1
(en)
*
|
2019-05-10 |
2020-11-19 |
Academia Sinica |
A vaccine comprising a nanoparticle encapsulating epitopes and adjuvant for neutraliying virus infection
|
|
EP4203994A4
(en)
*
|
2020-08-28 |
2024-07-03 |
Torigen Pharmaceuticals, Inc. |
Immune memory enhanced preparations and uses thereof
|